All posts by blogsonjapan

Japan News This Week 24 September 2017

Japan News.


The Latest Design Trend: Black and Burned Wood
New York Times

How Japan reacted to missile test

Japan PM Abe calls for global blockade of N. Korea
The Mainichi

‘A language we use to say sentimental things’: how shoegaze took over Asia

Japan’s New Conspiracy Law Expands Police Power
Japan Focus

Last Week’s Japan News on the JapanVisitor blog


Japan’s military, the oddly named Self Defense Forces, is extremely powerful. While it flies under the radar – intentionally so – if a shooting war were to break out in East Asia, Japan would hold its own against South Korea and maybe even China for now.

The ten most powerful militaries in the world are:

1. USA
2. Russia
3. China
4. India
5. France
6. Great Britain
7. Japan
8. Turkey
9. Germany
10. Egypt

Source: Global Firepower


Inside Track Japan For Kindle …continue reading


A Japanese generic company works on strategic lawsuit with a recently acquired US company to develop the US market

A Japanese generic company, Sawai Pharmaceutical Co. is planning to actively work on lawsuits in the US in cooperation with its US subsidiary, Upsher-Smith Laboratories Inc., the Nikkan Kogyo Shimbun (the Daily Industrial News) reported on August 25. Sawai acquired Upsher-Smith for $1,050 million on May 31 this year.

According to the article, Sawai will conduct invalidity search for patents which protect original drugs and of which remaining patent term is long until expired, to submit paragraph IV certifications. By invalidating patents for original drugs, Sawai expects to expand sales of its generic drugs. Sawai has a plan to release one or two generic drugs per year in the US, starting from early 2020’s, through this kind of activities.

Sawai obtained ANDA (Abbreviated New Drug Application) approval for Pitavastatin Tablets in February this year. It is said that this is the first ANDA approval based on a paragraph IV for Japanese generic manufacturers. It seems that Sawai doesn’t want to wait for expiration of patents, but rather wants to actively invalidate patents for original drugs. IP service companies who excel in patent invalidity search may become good partners for Sawai.

The Japanese government concerns about the growth of medical expenses in recent years. In 2016, the amount of total national medical expenses amounted to JPY 41.28 trillion, which includes drug dispensing cost JPY 7.49 trillion. The government is promoting the use of generics to reduce medical expenses and announced a plan to make penetration rate of generics increase to 80% by September in 2020 (cf. 69.8% in December 2016).

If Sawai goes well, other Japanese generic companies may follow the same approach as Sawai. I personally don’t want to see many patents for original drugs invalidated, …continue reading


Ending North Korean brinkmanship

Author: Vinod Saighal, New Delhi

Analysts across the world have begun to justify North Korean leader Kim Jong-Un’s brinkmanship on the grounds that he is securing the longevity of his regime against any action that the United States might take. As long as Kim knows that China will not join hands with the United States in taking him out, he will keep upping the ante — thumbing his nose, so to say, at the United States.

Missiles are driven past the stand with North Korean leader Kim Jong Un and other high ranking officials during a military parade marking the 105th birth anniversary of North Korea’s founding father, Kim Il Sung, in Pyongyang, 15 April 2017. (Photo: Reuters/Sue-Lin Wong).

US President Donald Trump may threaten fire and fury and an unimaginable scale of destruction, but he knows that the United States is on the horns of a dilemma. And now Russia too has come out in opposition to unilateral US action, insisting that dialogue is the only way out.

By the looks of it, Kim is not likely to stop his brinkmanship. But provoking the United States beyond a certain …continue reading